In this episode of Innovating Clinical Trials, hosts Liam Eves and Ted Trafford are joined by Selin, CEO and founder of Massive Bio, to discuss the challenges and opportunities for startups in the clinical trial space. Selin shares her expertise on what it takes to succeed in this highly complex and regulated industry. We provide some valuable advice for startup CEOs, emphasizing the importance of understanding the true pain points within pharma, focusing on solving critical problems, and knowing who will pay for the solution. We also highlightsthe difficulties startups face, from long revenue cycles to navigating the unique challenges of working with pharmaceutical companies, and stresses the need for resilience and dedication to overcome these hurdles.

In this episode of Innovating Clinical Trials, hosts Liam Eves and Ted Trafford continue their discussion with Selin Kurnaz, CEO and founder of Massive Bio, an AI-powered platform that connects cancer patients with clinical trials. The conversation centers around the critical challenges in oncology trial enrollment, from recruitment failures to the operational difficulties encountered in the "Last Mile." We discuss the need for transparency, education, and a rethinking of traditional clinical trial processes. Selin discusses the complexity of site selection, prescreening, and patient identification, highlighting that the current system often overlooks the operational steps that are crucial for successful trial participation.

In this episode of Innovating Clinical Trials, hosts Liam Eves and Ted Trafford are joined by Selin Kurnaz, CEO and founder of Massive Bio, an AI-driven platform designed to connect cancer patients with clinical trials.

Our conversation dives deep into the challenges of patient awareness, access, and logistical hurdles in trial enrollment. Selin shares how her personal experience with her uncle’s cancer diagnosis led to the creation of Massive Bio and her mission to streamline trial enrollment using technology.

We discuss the "Last Mile" problem and walk through how combining technological scale with personalized concierge services can help patients not only find relevant trials but also overcome the logistical and financial barriers that can prevent participation. With insights into the complexities of the clinical trial landscape, the discussion highlights the critical steps needed to bridge the gap between patients and life-saving treatments.